Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
Inhibitor Krebs <Medizin> Therapie Prostaglandinsynthase Aufsatzsammlung : Cox-2 : a new target for cancer prevention and treatment / volume editors, Andrew J. Dannenberg, Raymond N. DuBois  2003 1
 

Inhibitor, Lupus Coagulation -- See Lupus Coagulation Inhibitor


An antiphospholipid antibody found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications
  1
 

Inhibitor, Monoamine Oxidase -- See Monoamine Oxidase Inhibitors


A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
  1
Inhibitor Prostaglandinsynthase Krebs <Medizin> Prävention Aufsatzsammlung : Cox-2 : a new target for cancer prevention and treatment / volume editors, Andrew J. Dannenberg, Raymond N. DuBois  2003 1
Inhibitor Prostaglandinsynthase Krebs <Medizin> Therapie Aufsatzsammlung : Cox-2 : a new target for cancer prevention and treatment / volume editors, Andrew J. Dannenberg, Raymond N. DuBois  2003 1
 

Inhibitor, Proteasome -- See Proteasome Inhibitors


Compounds that inhibit the function or proteolytic action of the PROTEASOME
  1
 

Inhibitor Proteins, Cyclin-Kinase -- See Cyclin-Dependent Kinase Inhibitor Proteins


A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION
  1
 

Inhibitors, 5-Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES
  1
 

Inhibitors, 12-Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES
  1
 

Inhibitors, 15-Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES
  1
 

Inhibitors, ACE -- See Angiotensin-Converting Enzyme Inhibitors


A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility
  1
 

Inhibitors, Angiogenesis -- See Angiogenesis Inhibitors


Agents and endogenous substances that antagonize or inhibit the development of new blood vessels
  1
 

Inhibitors, Angiogenesis Factor -- See Angiogenesis Inhibitors


Agents and endogenous substances that antagonize or inhibit the development of new blood vessels
  1
 

Inhibitors, Angiogenetic -- See Angiogenesis Inhibitors


Agents and endogenous substances that antagonize or inhibit the development of new blood vessels
  1
 

Inhibitors, Angiogenic -- See Angiogenesis Inhibitors


Agents and endogenous substances that antagonize or inhibit the development of new blood vessels
  1
 

Inhibitors, Angiotensin-Converting Enzyme -- See Angiotensin-Converting Enzyme Inhibitors


A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility
  1
Inhibitors Angiotensin converting enzyme   4
 

Inhibitors, Arachidonate 5-Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES
  1
 

Inhibitors, Arachidonate 12-Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES
  1
 

Inhibitors, Arachidonate 15-Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES
  1
 

Inhibitors, Aromatase -- See Aromatase Inhibitors


Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones
  1
Inhibitors Aromatase Therapeutic use   2
Inhibitors Aspartic proteinases Therapeutic use : BACE : Lead Target for Orchestrated Therapy of Alzheimer's Disease / edited by Varghese John  2010 1
Inhibitors Bacterial cell walls Synthesis : Antimicrobial therapeutics reviews : the bacterial cell wall as an antimicrobial target / issue editor, Karen Bush  2013 1
 

Inhibitors, beta Lactamase -- See beta-Lactamase Inhibitors


Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES
  1
Inhibitors Beta lactamases Therapeutic use : Heterocyclic antitumor antibiotics / volume editor, Moses Lee ; with contributions by D.P. Arya [and others]  2006 1
 

Inhibitors, Capase Activation -- See Caspase Inhibitors


Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation
  1
 

Inhibitors, Caspase -- See Caspase Inhibitors


Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation
  1
 

Inhibitors, Caspase Activation -- See Caspase Inhibitors


Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation
  1
 

Inhibitors, Cell Growth -- See Growth Inhibitors


Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS)
  1
Inhibitors Cellulose : Cellulose biosynthesis inhibitors as tools for research of cell wall structural plasticity / Jesús Miguel Álvarez ... [and 5 others], editors  2012 1
 

Inhibitors, Chemical -- See Chemical inhibitors



--subdivision Inhibitors under individual enzymes and groups of enzymes, e.g. Amylases--Inhibitors; also subdivision Antagonists under other individual chemicals and groups of chemicals, e.g. Insulin--Antagonists; and subdivision Synthesis--Inhibitors under individual chemicals and groups of chemicals, e.g. Insulin--Synthesis--Inhibitors
  1
 

Inhibitors, Cholesterol -- See Anticholesteremic Agents


Substances used to lower plasma CHOLESTEROL levels
  1
  Inhibitors, Complement -- 2 Related Subjects   2
 

Inhibitors, COX-2 -- See Cyclooxygenase 2 Inhibitors


A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2
  1
 

Inhibitors, COX2 -- See Cyclooxygenase 2 Inhibitors


A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2
  1
Inhibitors Cyclic nucleotide phosphodiesterases Therapeutic use : Oral pharmacotherapy for male sexual dysfunction : a guide to clinical management / edited by Gregory A. Broderick  2005 1
Inhibitors Cyclin-dependent kinases : Prognostic and therapeutic applications of RKIP in cancer / edited by Benjamin Bonavida and Stavroula Baritaki  2020 1
Inhibitors Cyclin-dependent kinases Therapeutic use : Cyclin dependent kinase 5 (Cdk5) / Nancy Y. Ip, Li-Huei Tsai, editors  2008 1
 

Inhibitors, Cyclooxygenase 2 -- See Cyclooxygenase 2 Inhibitors


A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2
  1
Inhibitors Cyclooxygenase 2 : Inflammation in the pathogenesis of chronic diseases : the COX-2 controversy / edited by Randall E. Harris  2007 1
Inhibitors Cyclooxygenase 2 Therapeutic use : Cox-2 : a new target for cancer prevention and treatment / volume editors, Andrew J. Dannenberg, Raymond N. DuBois  2003 1
Inhibitors Cysteine proteinases   4
Inhibitors DNA topoisomerases : DNA topoisomerases and cancer / Yves Pommier, editor  2012 1
  Inhibitors, Enzyme -- 2 Related Subjects   2
Inhibitors Epidermal growth factor Receptors : Third-Generation EGFR Inhibitors : Overcoming EGFR Resistance and Toxicity Problems / Harun M. Patel, Rahul Pawara, Sanjay J. Surana  2019 1
 

Inhibitors, Growth -- See Growth Inhibitors


Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS)
  1
 

Inhibitors, HDAC -- See Histone Deacetylase Inhibitors


Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains
  1
 

Inhibitors, Histone Deacetylase -- See Histone Deacetylase Inhibitors


Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains
  1
Inhibitors Histone deacetylase : Histone deacetylase inhibitors in combinatorial anticancer therapy / Shabir Ahmad Ganai  2020 1
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next